Prudential Financial Inc Vir Biotechnology, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 425,369 shares of VIR stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
425,369
Previous 291,069 46.14%
Holding current value
$3.68 Million
Previous $2.59 Million 23.01%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$7.26 - $10.7 $975,018 - $1.44 Million
134,300 Added 46.14%
425,369 $3.19 Million
Q2 2024

Aug 13, 2024
BUY
$7.63 - $12.66 $1.13 Million - $1.88 Million
148,340 Added 103.93%
291,069 $2.59 Million
Q1 2024

May 14, 2024
SELL
$8.6 - $11.9 $2.78 Million - $3.84 Million
-322,760 Reduced 69.34%
142,729 $1.45 Million
Q4 2023

Feb 13, 2024
BUY
$7.76 - $10.29 $1.19 Million - $1.58 Million
153,420 Added 49.16%
465,489 $4.68 Million
Q3 2023

Nov 13, 2023
BUY
$9.14 - $24.62 $910,846 - $2.45 Million
99,655 Added 46.92%
312,069 $2.92 Million
Q2 2023

Aug 11, 2023
SELL
$23.2 - $27.29 $154,001 - $181,151
-6,638 Reduced 3.03%
212,414 $5.21 Million
Q1 2023

May 12, 2023
SELL
$22.26 - $30.85 $871,924 - $1.21 Million
-39,170 Reduced 15.17%
219,052 $5.1 Million
Q4 2022

Feb 14, 2023
SELL
$19.96 - $28.22 $49,800 - $70,408
-2,495 Reduced 0.96%
258,222 $0
Q3 2022

Nov 04, 2022
BUY
$18.26 - $31.1 $2.09 Million - $3.56 Million
114,505 Added 78.31%
260,717 $5.03 Million
Q2 2022

Aug 15, 2022
BUY
$19.08 - $26.7 $1.58 Million - $2.2 Million
82,555 Added 129.69%
146,212 $3.72 Million
Q1 2022

May 13, 2022
BUY
$21.19 - $40.01 $1.12 Million - $2.12 Million
52,882 Added 490.78%
63,657 $1.64 Million
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $136,887 - $238,812
4,420 Added 69.55%
10,775 $451,000
Q3 2021

Nov 15, 2021
BUY
$34.9 - $54.54 $53,397 - $83,446
1,530 Added 31.71%
6,355 $277,000
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $10,075 - $13,260
260 Added 5.7%
4,825 $228,000
Q1 2021

May 12, 2021
BUY
$26.34 - $83.07 $120,242 - $379,214
4,565 New
4,565 $234,000

Others Institutions Holding VIR

# of Institutions
220
Shares Held
87.6M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.15B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email